In some embodiments, the present disclosure pertains to a compound, comprising a transition metal complex having the formula Φ-[M (x,y)-L1 (w,v)-L2 (t,u)-L3]p+An−mZ−p-m. In an embodiment of the present disclosure Φ may be Λ. In another embodiment Φ may be Λ. In some embodiments of the present disclosure, M is a transition metal. In a related embodiment, p is an integer corresponding to the oxidation state of M. In some embodiments of the present disclosure, each of x, y, w, v, t, and u independently comprise R. In other embodiments, each of x, y, w, v, t, and u independently comprise S. In an embodiment of the present disclosure, each of L1, L2, and L3 independently is a ligand comprising a substituted diamine. In some embodiments, An− comprises a lipophilic anion, where m is from 1 to 3, and where Z− comprises an optional second anion.
展开▼
机译：在一些实施方案中，本公开内容涉及一种化合物，其包含具有式Φ-[M（x，y）-L 1 （w，v）-L 2的过渡金属配合物（t，u）-L 3 ] p + An - m Z - pm 。在本公开的实施例中，Φ可以是Λ。在另一个实施例中，Φ可以是Λ。在本公开的一些实施方案中，M是过渡金属。在一个相关的实施方案中，p是对应于M的氧化态的整数。在本公开的一些实施方案中，x，y，w，v，t和u中的每个独立地包含R。在其他实施方案中，x中的每个，y，w，v，t和u独立地包含S。在本公开的实施例中，L 1 ，L 2 和L 中的每一个3 独立地是包含取代的二胺的配体。在一些实施方案中，An -包含亲脂性阴离子，其中m为1至3，并且其中Z -包含任选的第二阴离子。
展开▼
